Menu
GeneBe

ARG2

arginase 2

Basic information

Region (hg38): 14:67619919-67651708

Links

ENSG00000081181NCBI:384OMIM:107830HGNC:664Uniprot:P78540AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ARG2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ARG2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
1
clinvar
3
missense
26
clinvar
1
clinvar
27
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
3
clinvar
3
Total 0 0 29 3 1

Variants in ARG2

This is a list of pathogenic ClinVar variants found in the ARG2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
14-67619982-C-A not specified Uncertain significance (Aug 14, 2023)2589445
14-67619987-A-T Likely benign (Jun 04, 2018)717631
14-67619995-C-G not specified Uncertain significance (Mar 02, 2023)2493482
14-67620085-G-A Benign (Feb 01, 2018)714579
14-67620953-G-C not specified Uncertain significance (Jan 03, 2024)3128437
14-67620954-C-G not specified Uncertain significance (Jun 05, 2024)3310541
14-67642210-A-G not specified Uncertain significance (Dec 16, 2023)3128439
14-67642305-G-A not specified Uncertain significance (Jul 25, 2023)2613720
14-67642316-A-T not specified Uncertain significance (Mar 14, 2023)2459699
14-67642317-G-C not specified Uncertain significance (May 04, 2022)2226528
14-67645647-G-A not specified Uncertain significance (Jan 04, 2024)3128440
14-67645675-G-A not specified Uncertain significance (Aug 17, 2021)2265312
14-67645740-A-C not specified Uncertain significance (Nov 17, 2023)3128441
14-67645767-C-A not specified Uncertain significance (Jul 05, 2022)2402785
14-67645788-G-C not specified Uncertain significance (Apr 03, 2023)2532278
14-67646644-G-A not specified Uncertain significance (Aug 10, 2023)2617865
14-67646649-A-G Likely benign (Jul 09, 2018)757604
14-67646662-T-C not specified Uncertain significance (Sep 20, 2023)3128442
14-67646681-G-A not specified Uncertain significance (Jul 28, 2021)2239823
14-67646692-G-T not specified Uncertain significance (Aug 21, 2023)2590464
14-67646976-C-G not specified Uncertain significance (May 01, 2022)2286913
14-67646979-G-T not specified Uncertain significance (Oct 02, 2023)3128443
14-67648051-C-A not specified Uncertain significance (Jan 10, 2022)2390468
14-67650779-G-A Benign/Likely benign (Oct 01, 2022)770239
14-67650811-T-C not specified Uncertain significance (May 22, 2023)2549483

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ARG2protein_codingprotein_codingENST00000261783 831923
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0001820.9761256580901257480.000358
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.3441761890.9300.000009182270
Missense in Polyphen5972.2070.8171842
Synonymous0.1536970.60.9770.00000337739
Loss of Function2.01918.30.4920.00000109202

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001010.000999
Ashkenazi Jewish0.0006950.000695
East Asian0.001740.00174
Finnish0.0001390.000139
European (Non-Finnish)0.0001600.000158
Middle Eastern0.001740.00174
South Asian0.0001960.000196
Other0.0004900.000489

dbNSFP

Source: dbNSFP

Function
FUNCTION: May play a role in the regulation of extra-urea cycle arginine metabolism and also in down-regulation of nitric oxide synthesis. Extrahepatic arginase functions to regulate L-arginine bioavailability to nitric oxid synthase (NOS). Arginine metabolism is a critical regulator of innate and adaptive immune responses. Seems to be involved in negative regulation of the survival capacity of activated CD4(+) and CD8(+) T cells (PubMed:27745970). May suppress inflammation-related signaling in asthmatic airway epithelium (PubMed:27214549). May contribute to the immune evasion of H.pylori by restricting M1 macrophage activation and polyamine metabolism (By similarity). In fetal dendritic cells may play a role in promoting immune suppression and T cell TNF-alpha production during gestation (PubMed:28614294). Regulates RPS6KB1 signaling, which promotes endothelial cell senescence and inflammation and implicates NOS3/eNOS dysfunction (PubMed:22928666). Can inhibit endothelial autophagy independently of its enzymatic activity implicating mTORC2 signaling (PubMed:25484082). Involved in vascular smooth muscle cell senescence and apoptosis independently of its enzymatic activity (PubMed:23832324). Since NOS is found in the penile corpus cavernosum smooth muscle, the clitoral corpus cavernosum and the vagina, arginase-2 plays a role in both male and female sexual arousal (PubMed:12859189). {ECO:0000250|UniProtKB:O08691, ECO:0000269|PubMed:12859189, ECO:0000269|PubMed:22928666, ECO:0000269|PubMed:23832324, ECO:0000269|PubMed:25484082, ECO:0000269|PubMed:27214549, ECO:0000269|PubMed:27745970}.;
Pathway
Arginine and proline metabolism - Homo sapiens (human);Amoebiasis - Homo sapiens (human);Arginine biosynthesis - Homo sapiens (human);Amino Acid metabolism;Urea cycle and metabolism of amino groups;Metabolism of polyamines;Metabolism of amino acids and derivatives;Metabolism;urea cycle;Arginine Proline metabolism;Urea cycle (Consensus)

Recessive Scores

pRec
0.487

Intolerance Scores

loftool
0.378
rvis_EVS
-0.05
rvis_percentile_EVS
50.22

Haploinsufficiency Scores

pHI
0.119
hipred
Y
hipred_score
0.570
ghis
0.509

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.965

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Arg2
Phenotype
homeostasis/metabolism phenotype;

Gene ontology

Biological process
urea cycle;ureteric bud development;adaptive immune response;negative regulation of type 2 immune response;nitric oxide biosynthetic process;striated muscle contraction;arginine catabolic process to ornithine;negative regulation of tumor necrosis factor production;innate immune response;regulation of interleukin-1 beta secretion;negative regulation of macrophage inflammatory protein 1 alpha production;negative regulation of chemokine (C-C motif) ligand 4 production;negative regulation of chemokine (C-C motif) ligand 5 production;negative regulation of defense response to bacterium;regulation of reactive oxygen species biosynthetic process;negative regulation of tumor necrosis factor secretion;negative regulation of interleukin-17 secretion;negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process;negative regulation of CD4-positive, alpha-beta T cell proliferation;negative regulation of interleukin-13 secretion;positive regulation of cellular senescence
Cellular component
cytoplasm;mitochondrion;mitochondrial matrix
Molecular function
arginase activity;manganese ion binding